{
    "clinical_study": {
        "@rank": "87465", 
        "acronym": "IRM-EP2", 
        "arm_group": {
            "arm_group_label": "Intervention", 
            "arm_group_type": "Experimental", 
            "description": "In case of positive D-dimer testing or in patients with a high clinical probability of PE, these patients have MRI protocol combined with venous ultrasonography of the legs. MRI includes 2 different sequences: Unenhanced steady-state-free precession sequences (SSFP) sequences and angiography sequences. (please see \\\\\\\"intervention section\\\\\\\" for more details). MRI readings will be performed centrally by two independent readers blinded to the results of diagnostic reference standard. Venous ultrasonography of the legs will be interpreted locally."
        }, 
        "brief_summary": {
            "textblock": "Magnetic resonance imaging (MRI) represents a promising technique but can not be used as an\n      alternative test to multidetector CT in patients with suspicion of pulmonary embolism (PE)\n      due to its low sensitivity and high proportion of inconclusive MRI. The purpose of this\n      study is to evaluate diagnostic performances of MRI combined with venous ultrasonography of\n      the legs in patients with suspicion of PE."
        }, 
        "brief_title": "Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism", 
        "condition": "Pulmonary Embolism", 
        "condition_browse": {
            "mesh_term": [
                "Embolism", 
                "Pulmonary Embolism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria :\n\n          -  age > or = 18 years\n\n          -  clinical suspicion of PE\n\n          -  Affiliate (e) to a social security\n\n          -  provide written informed consent\n\n        Exclusion criteria :\n\n          -  Unstable patient clinically in shock on arrival at the emergency department\n\n          -  Current pregnancy\n\n          -  Life expectancy less than 3 months (eg terminal cancer)\n\n          -  Follow up at 3 months impossible\n\n          -  Anticoagulation curative> 48 hours prior to inclusion\n\n          -  Cons-indication to spiral chest CT: allergy to contrast or creatinine clearance below\n             30 ml / min calculated by the Cockcroft\n\n          -  Cons-indication to MRI claustrophobia, presence of intraocular metallic implant or a\n             pacemaker, an allergy to gadolinium, morbid obesity (weight> 130 kg, anteroposterior>\n             60 cm diameter)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1058", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02059551", 
            "org_study_id": "P120133"
        }, 
        "intervention": {
            "arm_group_label": "Intervention", 
            "description": "In case of positive D-dimer testing or in patients with a high probability of PE, MRI and a venous ultrasonography of the legs are done.MRI protocol includes 2 sequences: 1-Unenhanced steady-state-free precession sequences (SSFP) are acquired first without ECG-gating or breath-holding in the axial plane in the multiphase cine mode, with 6 phases per location.The acquisition is repeated to cover 2-3 of the thorax, from the roof of the aorta to the diaphragm. 2- A pulmonary gradient recalled echo (GRE) sequence is performed in the axial plane.The acquisition is triggered to start when contrast enhancement occurred in the right ventricle.Two acquisitions are necessary to cover the anatomy. For each acquisition, 0.15 mL kg-1 body weight of DOTAREM Gadolinium is injected at a rate of 3 mL s-1 followed by an injection of 15 mL of normal saline at 3 mL s-1.Venous ultrasonography of the legs: the examination consists of a real-time B-mode examination of the common femoral and popliteal veins.", 
            "intervention_name": "MRI combined with venous ultrasonography of the legs", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pulmonary embolism", 
            "magnetic resonance imaging", 
            "venous ultrasonography of the legs", 
            "diagnostic performances"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": {
            "contact": {
                "email": "olivier.sanchez@egp.aphp.fr", 
                "last_name": "SANCHEZ Olivier, MD, PhD", 
                "phone": "+33156093487"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "H\u00f4pital Europ\u00e9en Georges Pompidou"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Diagnostic Performances of Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism", 
        "overall_contact": {
            "email": "olivier.sanchez@egp.aphp.fr", 
            "last_name": "SANCHEZ Olivier, MD, PhD", 
            "phone": "+33156093487"
        }, 
        "overall_official": {
            "affiliation": "Universit\u00e9 Paris Descartes; Sorbonne Paris Cit\u00e9; Service de Pneumologie et Soins Intensifs, H\u00f4pital Europ\u00e9en Georges POmpidou; AP-HP", 
            "last_name": "SANCHEZ Olivier, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: comit\u00e9 de protection des personnes IDF IV (CPP IDF IV)", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du m\u00e9dicament (ANSM)"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "sensitivity, specificity, positive and negative likelihood ratios of the combination of MRI and venous ultrasonography of the legs", 
            "measure": "To assess diagnostic performances of MRI combined with venous ultrasonography of the legs in reference to Multi-Detector Computed Tomography and 3 months clinical follow-up", 
            "safety_issue": "No", 
            "time_frame": "51 months"
        }, 
        "reference": [
            {
                "PMID": "23652845", 
                "citation": "Revel MP, Sanchez O, Lefort C, Meyer G, Couchon S, Hernigou A, Niarra R, Chatellier G, Frija G. Diagnostic accuracy of unenhanced, contrast-enhanced perfusion and angiographic MRI sequences for pulmonary embolism diagnosis: results of independent sequence readings. Eur Radiol. 2013 Sep;23(9):2374-82. doi: 10.1007/s00330-013-2852-8. Epub 2013 May 8."
            }, 
            {
                "PMID": "22321816", 
                "citation": "Revel MP, Sanchez O, Couchon S, Planquette B, Hernigou A, Niarra R, Meyer G, Chatellier G. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the 'IRM-EP' study. J Thromb Haemost. 2012 May;10(5):743-50. doi: 10.1111/j.1538-7836.2012.04652.x."
            }, 
            {
                "PMID": "20368649", 
                "citation": "Stein PD, Chenevert TL, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Jablonski KA, Leeper KV Jr, Naidich DP, Sak DJ, Sostman HD, Tapson VF, Weg JG, Woodard PK; PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med. 2010 Apr 6;152(7):434-43, W142-3. doi: 10.7326/0003-4819-152-7-201004060-00008."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02059551"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "3-month thromboembolic events rate in patients who were left untreated on the basis of negative D-dimer measurement or negative combination of MRI + venous ultrasonography of the legs", 
                "measure": "To assess the diagnostic accuracy of a strategy combining clinical probability, D-dimer measurement, MRI and venous ultrasonography of the legs for PE", 
                "safety_issue": "No", 
                "time_frame": "51 months"
            }, 
            {
                "description": "sensitivity, specificity, positive and negative likelihood ratios of each MRI sequence (unenhanced 2D steady-state-free-precession (SSFP) and contrast-enhanced 3D angiographic MR sequences) combined or not to venous ultrasonography of the legs in reference to Multi-Detector Computed Tomography and 3 months clinical follow-up", 
                "measure": "To assess diagnostic performances of each MRI sequence combined or not to venous ultrasonography of the legs in reference to Multi-Detector Computed Tomography and 3 months clinical follow-up", 
                "safety_issue": "No", 
                "time_frame": "51 months"
            }, 
            {
                "description": "Kappa coefficient of concordance calculated on the diagnoses on MRI by two radiologists blinded to the diagnostic reference strategy (multidetector CT angiography and follow-up 3 months).", 
                "measure": "inter-reader agreement for MRI", 
                "safety_issue": "No", 
                "time_frame": "51 months"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}